KLOW
KLOW is a four-peptide research blend of BPC-157, TB-500, GHK-Cu and KPV. Supplied as a lyophilized powder in sealed vials. Each batch has its own certificate of analysis (COA), which opens when you scan the QR code on the label. For laboratory research use only. Not for human or veterinary use.
KLOW blend research profile
KLOW is a multi-component research material combining four compounds in one vial: GHK-Cu, KPV, BPC-157 and the TB-500 fragment of thymosin beta-4. It has the same three components as GLOW with the α-MSH-derived tripeptide KPV added. Each component's identity is shown on the certificate of analysis. The literature describes each compound separately; there are no published studies on this blend.
Specifications
- Composition
- GHK-Cu 50 mg + KPV 10 mg + BPC-157 10 mg + TB-500 10 mg per vial (80 mg total)
- GHK-Cu
- Gly-His-Lys copper(II) complex; C14H22CuN6O4, ≈ 401.9 g/mol
- KPV
- Lys-Pro-Val; C16H30N4O4, ≈ 342.4 g/mol
- BPC-157
- GEPPPGKPADDAGLV; C62H98N16O22, ≈ 1419.6 g/mol
- TB-500
- Ac-LKKTETQ (thymosin beta-4 residues 17–23); C38H68N10O14, ≈ 889.0 g/mol
- Form
- Lyophilized powder, sealed vial
- Storage
- Keep sealed, protected from light and moisture; follow the label
- Testing
- HPLC purity and mass spectrometry identity, per lot. Scan the QR code on the vial for the certificate of analysis.
Published research
- GHK-Cu: isolated from human plasma (Pickart & Thaler, Nature, 1973); fibroblast extracellular matrix synthesis in vitro (Maquart et al., 1988).
- KPV: PepT1-mediated uptake in intestinal epithelial cells and mouse colitis models (Dalmasso et al., Gastroenterology, 2008; Kannengiesser et al., Inflamm Bowel Dis, 2008).
- BPC-157: rat tendon models (Staresinic et al., J Orthop Res, 2003); rodent gastrointestinal models (Duzel et al., World J Gastroenterol, 2017).
- TB-500 / thymosin beta-4: actin sequestration (Safer et al., J Biol Chem, 1991); mouse skin wound models (Huang et al., Proteomics, 2006).
Frequently asked questions
How does KLOW differ from GLOW?
KLOW adds 10 mg of KPV to the GLOW components (GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg), for 80 mg in total.
Is there published research on this blend?
No. Published studies examine each component on its own; we are not aware of literature on this combination. The research notes above summarize each component separately.
How do I verify my lot?
Scan the QR code on the vial. It opens the certificate of analysis for that lot, with HPLC purity and the mass spectrometry identity result.
For laboratory research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure or prevent any disease. Literature references are provided for scientific context and do not describe this product's suitability for any use.
You might also need.
BPC/TB500 Blend
CJC No DAC / Ipamorelin
BPC-157 vs TB-500: two research peptides compared · Reading a mass spectrum on a peptide COA: m/z, charge states and adducts · GHK-Cu blends explained: GLOW and KLOW compositions · CJC-1295 with and without DAC: what the names mean · Short peptide bioregulators: an overview for researchers · Why a peptide's molecular weight can differ: salts, caps and oxidation · Thymosin alpha-1: structure, history and research · Epitalon (AEDG): what the research covers · KPV: the α-MSH tripeptide explained · MOTS-c: the mitochondrial-derived peptide explained · Adamax and Semax: what is known about this analog · Selank: the tuftsin-derived heptapeptide explained · SNAP-8 vs Argireline: two SNAP-25 mimic peptides compared · AHK-Cu vs GHK-Cu: comparing two copper tripeptides · GHK-Cu: structure, history and published research · HPLC purity: what the percentage on a COA means · Mass spectrometry: how a peptide's identity is confirmed · How to verify a lot with the QR code on the vial · Lyophilized peptides: what they are and how labs store them · How to choose a research compound supplier: 7 points